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Background: Ischemic preconditioning, direct or remote, has been 
known to protect the myocardium against lethal ischemic injury. 
Expression of neural cell adhesion molecule (NCAM) is also known to 
have protective and regulating effects on myocardial infarction. The 
aims of the present study are; (1) to compare the effect of direct versus 
remote type of ischemic preconditioning on myocardial protection, (2) 
to examine the expression level of neural cell adhesion molecule 
(NCAM) in acute stage of myocardial infarction, and (3) to demonstrate 
if the expression of NCAM is involved in myocardial ischemic 
preconditioning models in rat. 
Methods: Ischemic preconditioning was induced in Sprague-Dawley 
(SD) rat by three cycles of 3 minutes occlusion of the left anterior 
descending coronary artery (Direct group, n=7) or left femoral artery 
(Remote group, n=7), followed by 5 minutes of reperfusion. Myocardial 
ischemia was produced by ligation of the left anterior descending 
coronary artery for 50 minutes, followed by reperfusion for 50 minutes 
(Control group, n=7). Infarct and at risk area was determined by 2,3,5-
triphenyltetrazolium chloride staining. Immunohistochemistry was 
performed with anti-NCAM rabbit polyclonal antibody H-300. 
Expression level of NCAM of infarct area was presented as the ratio of 
intensity of infarct area to intensity of the reference area.  
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Results: The direct ischemic preconditioning significantly decreased 
the infarct size (p = 0.003) when compared with that of the control 
group. The infarct size was also decreased in the remote group, 
however, there was no significant difference when compared with that 
of the control group (p = 0.269). The infarct size in the direct group was 
smaller than that in the remote group without significant difference 
between two groups (p = 0.097). In the immunohistochemistry, the 
expression of NCAM in the direct group was lower than the other 2 
groups; however, there was no significant difference in the NCAM 
expression level among the three groups.  
Conclusions: Ischemic preconditioning to the left anterior descending 
coronary artery territory provided a myocardial protection for ischemia-
reperfusion injury to the same coronary artery territory. However, the 
protective effect of ischemic preconditioning to the femoral artery was 
not significant in the rat myocardium infarction model. The expression 
of NCAM seemed to be down-regulated in the acute stage of 
myocardial infarction and showed no differences in the groups of 
ischemic preconditioning in rat.    
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Ischemic preconditioning (IPC) is defined as some kind of myocardial 
protection by rendering the ischemic territory resistant to a subsequent 
longer period of ischemia after the transient episodes of myocardial 
ischemia and reperfusion. Since the concept of ischemic preconditioning 
was firstly described by Murry and colleagues [1], numerous animal and 
clinical studies has been performed to identify the basic mechanism of IPC 
and to evaluate the cardioprotective effects on myocardial ischemic injury. In 
the experimental studies, almost all previous reports concluded that the IPC 
improved the myocardial preservation while the value of IPC remained 
controversial in the clinical investigations [2].  
On the other hand, there are two types of IPC, which are direct and remote 
IPC. Despite a variety of results favoring the cardioprotective effect of the 
direct type of IPC, the clinical application is restricted, due to the direct 
invasiveness to the myocardium. Therefore, the notion of remote ischemic 
preconditioning (RIPC) applied in other coronary arteries, including the 
circumflex artery (intra-cardiac IPC), mesenteric or renal artery (inter-organ 
IPC), and femoral or brachial artery (distant IPC) has been well established, 
and several underlying mechanisms have also been investigated [3-5]. In 
RIPC to the far distant organs, including limbs, however, some arguments 
regarding the true protective effect on ischemic myocardium still remain. 
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Moreover, there were lacked studies that compared direct IPC with remote 
IPC.  
Expression of neural cell adhesion molecule (NCAM, CD 56) is also known 
to have protective and regulating effects on myocardial infarction and 
congestive heart failure [6]. However, there was no study with regard to the 
role of NCAM in acute stage of myocardial infarction and ischemic 
preconditioned heart.  
The aims of the present study are; (1) to compare the effect of direct versus 
remote type of ischemic preconditioning on myocardial protection, (2) to 
examine the expression level of neural cell adhesion molecule (NCAM) in 
acute stage of myocardial infarction, and (3) to demonstrate if the 
expression of NCAM is involved in myocardial ischemic preconditioning 














All animals were treated in compliance with the Guide for the Care and Use 
of Laboratory Animals (National Academy of Science, Washington, D.C.). 
Animal use protocols were approved by the Institutional Animal Care and 
Use Committee (IACUC) in Seoul National University Hospital Biomedical 
Research Institute (Approval Number: 04-2010-095-0).  
 
1. Surgical procedures 
Female Sprague-Dawley (SD) rats weighing 250g to 300g were used in the 
present study. Anesthesia of rats was performed with inhalation of isoflurane 
for induction, followed by intraperitoneal administration with combination of 
Zoletil 50 and Rompun for maintenance. A tracheostomy was performed and 
the rat was intubated with a cannula connected to a ventilator. To prevent 
the atelectasis, positive pressure ventilation was maintained during the 
operation. A left thoracotomy was performed and approached via the fifth 
intercostals space. After the pericardium was opened, the left atrial 
appendage was moved to expose the left coronary artery, close to the place 
of origin. Myocardial infarction was induced by ligating the left anterior 
descending coronary artery (LAD), approximately 2mm from its origin with 6-




2. Experimental protocols  
In the ‘Control group’ (n=7), rats underwent 50 minutes of ischemia, followed 
by 50 minutes of reperfusion. After reperfusion, the heart was quickly 
excised and heparinized via coronary ostium, while clamping the ascending 
aorta. The coronary artery, which had been ligated for infarction, was again 
occluded by 6-0 nylon suture, and then 1% Evans blue was perfused to 
stain the myocardium. The heart was cut into 2mm slices and the slices 
were then incubated in 2,3,5,-triphenyltetrazolium chloride (TTC, Sigma 
Chemical, St. Louis, MO), which was dissolved in a 100 mmol/L phosphate 
buffer, for 15 minutes. In the ‘Direct group’ (n=7), the LAD close to its origin 
was snared with 6-0 nylon double suture. After a snare occluder was placed 
into the ring formed by double suture, the suture ends were crossed and 
tugged from both sides for 3 minutes of LAD occlusion, and then were 
released for 5 minutes of reperfusion. Ischemic preconditioning was induced 
by three cycles of LAD occlusion, followed by reperfusion. In the ‘Remote 
group’ (n=7), the femoral artery of the left hind limb was dissected and 
snared with a 6-0 nylon suture for occlusion by crossing the suture. RIPC 
was elicited by three cycles of 3 minutes of the left femoral artery occlusion 
interspersed with 5 minutes of reperfusion before 50 minutes of regional 
ischemia in the heart. The experimental protocols and time-lines are shown 




3. Determination of Infarct size and area at risk 
We always used the mid portion of left ventricle among all sliced sections of 
myocardium for measuring the infarct size, and comparing it between three 
groups on the same cross section. Infarct (white zone) and at risk (red zone) 
areas were measured by plainmetry, using Image J v1.44 software (NIH, 
Bethesda, MD) [7]. Infarct size was expressed as the ratio of infarct area 
(white zone) to whole the ischemia area, which consisted of infarct and at 
risk areas (white plus red zone) (Fig. 2).  
 
4. Immunohistochemistry 
The tissue was fixed by immersion in 10% neutral buffered formalin for 
24~36 hours at room temperature. Fixed tissue specimens were dehydrated 
and embedded in paraffin, according to the standard procedures. Paraffin 
sections of 4 μm thickness were cut and placed on silane-coated glass 
slides. After deparaffinization, using serial xylene and alcohol, antigen was 
retrieved by heating for 10 minutes. Endogeneous peroxidase activity was 
blocked, using 0.3% H2O2 in distilled water for 5 min. The glass slides were 
washed in phosphate- buffered saline (PBS, 3 times, 5 min each) and 
mounted with 1% normal serum in PBS for 30 min. Anti-NCAM rabbit 
polyclonal antibody H-300 (Santa Cruz, CA, USA) diluted to 1:50 in PBS 
was applied for two hours at room temperature. The slides were incubated 
6 
 
with biotinylated anti-rabbit serum (second antibody) diluted to 1:100 in PBS 
for 40 min, followed by washes in PBS (3 times, 5 min each). Avidin-biotin-
peroxidase complex (ABC) (ABC-Elite, Vector Laboratories, CA, USA) at a 
dilution of 1:100 in PBS was applied for 20 min. After washing in PBS (3 
times, 5 min each), the detection reaction was carried out with 3,3-
diaminobenzidine (DAB), and nuclei were counterstained with Meyer's 
hematoxylin.  
 
5. Image analysis of immunohistochemistry 
Images were captured with Olympus light microscope BX43 (Olympus, 
Japan) and a digital camera DP26 (Olympus, Japan) with CellSens software 
(Olympus, Japan) with pixel size 1280x960. Three images at the lateral wall 
and anterior wall of the left ventricle with mid portion in between were 
obtained in each case. After the same image adjustment parameter was 
applied to all images with Image J v1.44 (NIH, Bethesda, MD) [7], pixels 
over the threshold were counted. To adjust inter-individual variation in 
immunostaining pattern of NCAM, lateral wall of left ventricle with non-
ischemic change confirmed in chemical staining was used as a reference 
area. Pixel count of lateral wall was used as a reference value in each case 
for the correction of the level of NCAM expression in the tissue. 
Expression level of NCAM of infarct area was presented as ratio of intensity 
of anterior wall (infarct area) to intensity of reference point (non-ischemia 
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area) (Fig. 2).  
 
6. Statistical analysis 
Statistical analysis was performed using the SPSS software package 
(Version 12.0, SPSS Inc, Chicago, IL). Continuous variables were 
expressed as the mean ± standard deviation, median and ranges, or 
proportions. Comparison between the 3 groups was performed with the one-
way ANOVA. All statistical tests were two-tailed, and all P values of less than 


















1. Myocardial infarct size 
Mean myocardial infarct size in control, direct, and remote group were 
0.68±0.13, 0.35±0.19, and 0.54±0.17, respectively. The infarct size of the 
direct group, which underwent the LAD IPC, was significantly decreased 
compared with those of no IPC group (Control group) (p = 0.003). However, 
RIPC to the femoral artery (Remote group) before regional heart ischemia 
slightly decreased the infarct size. Therefore, there was no significant 
difference between the remote and direct groups (p =0.097), and the infarct 
size of the remote group was similar with those of the control group (p 
=0.269). Infarct size of all groups and comparison analysis between the 
groups were presented in Table 1.   
 
2. Expression level of CD 56 (NCAM) in infarct area 
Ventricular myocardial tissues of three rats included in each group were 
stained with anti-NCAM rabbit polyclonal antibody H-300 for 
immunohistochemistry. Level of expression in intercalated discs of 
myocardial cell showed the decreasing patterns in infarct area compared 
with non-ischemia area in all myocardium (Fig. 3). While the NCAM 
expression level between the control and remote groups was similar 
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(Control vs. Remote group; 0.74 ± 0.23 vs. 0.87 ± 0.35, p=0.589), the level 
of NCAM expression in direct group was decreased compared with those in 
other two groups. However, the statistical significance in each comparison 
analysis was not existed (Direct vs. Control group; 0.50 ± 0.13 vs. 0.74 ± 
0.23, p=0.233, Direct vs. Remote group; 0.50 ± 0.13 vs. 0.87 ± 0.35, 
p=0.063). Expression level of NCAM in infarct and non-ischemia area, and 
















The current study revealed three main findings. First, the direct IPC 
significantly decreased the myocardial infarct size, while the RIPC to the 
femoral artery did not show the significant reduction of infarct size in rat 
heart. Second, the expression level of NCAM in infarct area showed the 
decreasing pattern compared with that of the non-ischemia area in the acute 
stage of myocardial infarction. Third, the NCAM expression was more down-
regulated in infarct area of direct group than in infarct area of other two 
groups without the statistical significance.  
A brief period of repeated ischemia and reperfusion has been shown to 
protect the myocardium against lethal injury, following subsequent sustained 
ischemia, and the phenomenon is termed as ischemic preconditioning (IPC) 
[1]. According to the results of a variety of previous experimental studies 
related with IPC, it has been known that myocardial infarct size is 
significantly decreased after IPC. Moreover, the concept of IPC at a remote 
site from the target organ was first described by Przyklenk and colleagues, 
and termed remote ischemic preconditioning (RIPC) [8]. RIPC has been 
applied in non-targeted coronary arteries (intra-cardiac IPC), mesenteric or 
renal artery (inter-organ IPC), and femoral or brachial artery (distant IPC). 
Since the clinical application of direct IPC induced by transient ischemia and 
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reperfusion to the target coronary territory may be limited due to the 
practical difficulties and the possibilities of myocardial dysfunction resulted 
from the procedure itself, currently, RIPC appears to be more attractive and 
popular in the diverse clinical situation, including myocardial infarction, 
coronary artery bypass surgery [9], abdominal aortic aneurysm repair [10], 
and even in orthotopic heart transplantation [11]. However, there were some 
arguments regarding the true protective effect of RIPC to the limbs because 
the transient limb ischemia usually showed to be a potent preconditioning 
stimulus in humans and larger animals [12]. In addition, there were lacked 
studies that compared direct IPC with remote IPC.  
In the present study, the three cycles of direct IPC to the LAD, which was a 
coronary territory subjected to the sustained ischemia, significantly 
decreased the myocardial infarct size while the RIPC to the femoral artery 
showed the slightly decreased or similar patterns of infarct size compared 
with no IPC group. Rather, there was much difference in the infarct size 
between direct and remote IPC group despite no statistical difference. 
Therefore, the cardioprotective effect of IPC may be reduced in RIPC to the 
far distant organs, such as limbs, especially in rats that have smaller 
proportion of blood flow in limbs than other major organs.  
Although it is well established by numerous experimental studies that 
ischemic preconditioning provides the enhanced tolerance of the 
myocardium to the prolonged ischemic insult, however, the precise 
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mechanisms are still unknown. Basically, ischemic preconditioning is 
considered to cause an increase in adenosine monophosphate (AMP) and 
cyclic AMP, thereby attenuating the degradation of adenosine triphosphate 
(ATP) and the accumulation of glycolytic intermediates and lactate 
production during sustained ischemia [13] in the view of metabolic theory. 
Furthermore, there have been presented with several possible and 
multifactorial mechanisms related with the ischemic preconditioning, such as 
stimulation of beta adrenergic receptors [13], activation of signaling 
pathways, including mitochondrial KATP channels and protein kinase C (PKC) 
[14,15], generation of reactive oxygen species (ROS) and endogenous nitric 
oxide (NO) [16], innate immunity pathways activated by tumor necrosis 
factor alpha (TNF-α) in leukocyte [17], modification of gene expression in 
myocardium [18], and Akt pathway and glycogen synthase kinase-3β (GSK-
3β) activation [19]. Therefore, various types of endo- or exogenous 
substances, including κ- or δ- opioid receptor agonists [14,20,21], adenosine 
[15], bradykinin agonist [16,22-25], and adenylate cyclase agonist [13] have 
been investigated, which are able to mimic the protective effect of ischemic 
preconditioning. However, the complete signaling pathway of protective 
effect remains unclear, and the exact relationship between these 
mechanisms is not clearly defined. In addition, the function and importance 
of mechanisms and various endo- or exogenous triggers are controversial. 
These uncertainties may reflect multiple signaling paths in preconditioning. It 
13 
 
is also possible different paths may mediate the differing protective effects 
[15].  
In this regard, we hypothesized that neural cell adhesion molecule (NCAM, 
CD56), which was known for a regulating factor of myocardial protection, 
would be involved in the mechanisms related to the myocardial response 
against acute myocardial infarction and IPC.  
Although the basic role of NCAM was presented as a major regulator of 
development, cell survival, migration, and neurite outgrowth in the nervous 
system [6], and mediates the intercellular adhesion in the nervous system 
and skeletal muscle [26], several previous studies demonstrated that the 
expression of NCAM was enhanced and played a protective role against the 
metabolic stress, such as congestive heart failure (CHF) and myocardial 
infarction (MI) in rat and mouse cardiomyocytes. There was significant up-
regulation of NCAM in infarct area at subacute (7 days after surgery) and 
chronic phase (12 months after surgery) of MI, which was induced by 
ligating the left anterior descending coronary artery [6]. Moreover, the 
overexpression of NCAM was identified as a local response of 
cardiomyocyte to scar formation in ischemic cardiomyopathy of human and 
rat models [26]. However, there was no previous report with regard to the 
role of NCAM in ischemic preconditioned MI heart. It has been wondered 
whether the similar patterns of NCAM expression level would be observed in 
acute MI model. In our experiment, the NCAM staining of infarct area in the 
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direct group showed much weaker than those in the control and femoral 
group, although there was no statistical significant difference due to a very 
small number of cases. Interestingly, the NCAM expression of infarct area 
was decreased than those of non-ischemic area in all the groups. From 
these results, therefore, we deduced that the NCAM, which was a kind of 
cell surface protein up-regulated under subacute and chronic stress 
conditions, was down-regulated in cardiac myocytes under acute infarction 
phase because of the active degradation of the myocardial cell. Moreover, 
NCAM might not be relative to the mechanism of ischemic preconditioning 
on myocardial protection because NCAM expression of infarct area was 
down-regulated in the direct group, while the infarct size of the same group 
was significantly decreased. It is possible that the up-regulation of NCAM 
may be impeded by the enhancement of ischemic preconditioning, which 
has the other cardioprotective mechanism on myocardial protection.  
In conclusion, the direct ischemic preconditioning provides the myocardial 
protection for sustained ischemia while the remote ischemic preconditioning 
to the femoral artery shows no significant cardioprotective effect in rats. 
NCAM may be down-regulated in acutely stressed cardiomyocytes, and the 
protective role may not be associated with ischemic preconditioning.    
 
Limitation 
There are limitations to the present study that must be recognized. First, we 
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failed to demonstrate the protective effect of remote preconditioning 
although that of direct ischemic preconditioning was significant. This might 
result from small sample size in the rat study. Second, 
immunohistochemistry is qualitative or quasi-quantitative rather than 
quantitative, thus it is appropriate for localization of macromolecules in 
tissue or subcellular organization. For the precise quantitation of molecules, 
western blotting for protein, and northern blotting or quantitative RT-PCR for 
mRNA should be used together with tissue IHC. Third, the present animal 
model is an acute infarction model demonstrating biochemical alterations 
instead of identifiable morphological changes. In this regard, the current 
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Table 1. Infarct size data and group comparison 
 Control group Direct group Remote group 






1 257 0.702 251 0.609 253 0.688 
2 254 0.630 233 0.593 263 0.549 
3 258 0.426 248 0.330 254 0.799 
4 263 0.750 265 0.228 258 0.469 
5 253 0.683 260 0.109 248 0.594 
6 260 0.779 253 0.276 249 0.392 
7 250 0.801 262 0.301 259 0.302 
Mean 0.68±0.13* 0.35±0.19 0.54±0.17 
Comparison of mean infarct size of myocardiums without ischemic 
preconditioning (IP) (control group), those with ischemic preconditining of 
LAD (direct group), ischemic preconditioned myocardiums of femoral artery 
(remote group).  









Table 2. Expression level of CD 56 (NCAM) in infarct area and group 
comparison 
 Control group Direct group Remote group 
1 0.95 0.65 0.84 
2 0.50 0.42 0.84 
3 0.78 0.44 0.78 
Mean 0.74 ± 0.23 0.50 ± 0.13 0.87 ± 0.35 
Comparison of NCAM expression level in infarct area (Intensity of infarct 





















Figure 1. Diagram of experimental protocols and time-lines 
 
 
IPC = ischemic preconditioning, LAD = left anterior descending, FA = 
femoral artery 
 
In all experiments, rats underwent 50 minutes of ischemia followed by 50 
minutes of reperfusion after the rest (Control group) or ischemic 
preconditioning (IPC, Direct and Remote group) period. IPC was induced by 
three cycles of 3 minutes of occlusion and 5 minutes of reperfusion to left 
anterior descending coronary artery (LAD) or left femoral artery (FA). After 
then, heart was quickly excised and stained with 1% Evans blue and 2,3,5,-





Figure 2. Measurement of infarct area and NCAM expression in 
myocardium using chemical and immunohistochemical staining 
(A)                                          (B) 
 
1: Non-ischemia area              1. Reference point (non-ischemia area) 
2: at risk area (red zone)            2. Anterior wall (infarct area) 
3: infarct area (white zone) 
* Infarct size: white zone / (red + white zone)  
 
(A) Photograph obtained after staining with Evans blue and TTC of the 
infarcted heart subjected to ischemic preconditioning. Hearts were cut into 
2mm of transverse slices and stained with TTC to differentiate infarct area 
(white zone) from at risk area (red zone). Infarct size was expressed as ratio 
of infarct area (white zone) to whole ischemic area (white plus red zone). 








NCAM rabbit polyclonal antibody diluted to 1:50 in PBS. Level of NCAM 
protein expression was evaluated by comparing pixel counts using image 






















Figure 3. Immunohistochemical study of myocardium from different 
experimental groups using rabbit anti-rat NCAM antibody 
1. Control group 
        
(A) Non-ischemia area (reference point)  (B) Infarct area (anterior wall)                        
 
2. Direct group 
         











3. Remote group 
     
(A) Non-ischemia area (reference point)   (B) Infarct area (anterior wall)       
 
Intense expression of NCAM is noted in intercalated discs of ventricular 
myocardial cells. Staining intensity at the intercalated discs is mildly 
decreased and patch or incomplete staining pattern (arrow) is more frequent 
in anterior wall (infarct area, (A)) compared to reference point (non-ischemia 
area, (B)) in all groups. Representative figures are arranged in order of 








국   
 
목 :  심장  좌 하행지 상동맥에 직  허  처 를 한 경우  
퇴동맥에 원격 허  처 를 한 경우에 좌 하행지 상동맥 심근
역  허 에 해 미 는 심근 보  효과를 하고자 하 다. 그리고 
심근 보  조  인자  알 진 neural cell adhesion molecule 
(NCAM)   도를 인하여,  심근경색 하에  NCAM  
심근 보  효과  허  처  , 그리고 허  처  법에 
른 차이를 규명해 보고자 하 다. 
법: Sprague-Dawley (SD) 랫드를 이용하여, 조군  허  처  
없이 좌 하행지 상동맥  50분간 결찰하여 심근 허  하 고 
(Control group, N=7), 실험군   군  나누어 각 군  해당 동맥
에 3분  허 과 5분  재 류를 3번씩 복하여 허  처 를 시행한 
후 조군과 마찬가지  좌 하행지 상동맥  허  하 다. 실험
군  좌 하행지 상동맥에 직  허  처 를 시행하거나 (Direct 
group, N=7), 퇴동맥에 원격 허  처 를 시행하 다 (Remote 
group, N=7). 심장  출한 후 1% Evans blue  2,3,5-
triphenyltetrazolium chloride (TTC) 염색  시행하여 경색이 일어난 
부  (Infarct area)  경색 주변부  (at risk area) 를 하여 그 
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 허  처  효과를 평가하 다. 각 군당 3마리에 는 Neural 
cell adhesion molecule (NCAM; CD 56) 에 한 항체를 이용하여 면역
조직 학염색  시행한 후 그  도를 하 다.       
결과: 1% Evans blue  2,3,5-triphenyltetrazolium chloride (TTC) 
염색에  Direct group  경색부   Control group 에 해 
하게 감소하 다 (P=0.003). Remote group 에  경색 부 는 
Control group 보다 감소하 나 통계  한 차이를 보이지 않
았다 (P=0.269). 한편, Direct group  경색부 는 Remote group 에 
해 감소한 양상  보 나  군간 통계 는 한 차이는 찰
지 않았다. 한편 CD 56 항체를 이용한 면역조직 학염색 결과, 경색부
 NCAM  경색 부 에 해 감소하 고,  군간 에 있
어 Direct group  다른  군에 해 NCAM 이 감소하 나 
한 차이를 보이지 않았다. 
결 : 에  좌 하행지 상동맥에  직  허  처 는 허  처
를 시행하지 않  군에 해 심근보  효과가 있었 나, 퇴동맥에  원
격 허  처 는  심근경색 모델에  한 보  효과를 보이지 않
았다. NCAM   심근경색 상태에 는 감소하는 양상  보 고 
허 처 를 시행한 군들에  한 차이를 보이지 않았다. 라  허




주요어 : 심장, 허  처 , 신경 포 착분자 
 
학번 : 2011-21849   
 
